Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04399460
Other study ID # DFC_LTDairy_2019
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date September 1, 2020
Est. completion date September 30, 2023

Study information

Verified date June 2023
Source University of Toronto
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The proposed study looks at the effect of long-term diet modification with or without full-fat dairy products or restrictive eating on body weight, body composition and cardiometabolic markers in healthy overweight/obese men and women.


Description:

A total of 93 males and females will participate in the study at the University of Toronto. At the beginning and after 12 weeks, body weight, composition will be measured through Bodpod scans. Resting metabolic rate and thermogenesis will be measured by indirect calorimetry. Also, fecal samples will be collected for gut microbiome profiling along with blood for glucose, insulin, hormones, triacylglycerol, HbA1c, short-chain fatty acid, red blood cells and FGF21. Urine samples will be collected throughout the study. A followup session at 16 weeks will reassess previous measures.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 93
Est. completion date September 30, 2023
Est. primary completion date September 30, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 30 Years to 50 Years
Eligibility Inclusion Criteria: - BMI: = 27 and = 34.9 kg/m2 - Fasting serum glucose: = 7 mmol/L - Low =1 serving of dairy consumption - Waist circumference >88cm (women) and >102cm (men) - Willing to maintain habitual diet, physical activity pattern, and body weight throughout the trial. - Willing to maintain current dietary supplement use throughout the trial. On test days, participant agrees not to take any dietary supplements until dismissal from the study. Failure to comply will result in a rescheduled test visit. - Willing to abstain from alcohol consumption for 24 h prior to all test visits. - Willing to avoid vigorous physical activity for 24 h prior to all test visits. - Understanding the study procedures and willing to provide informed consent to participate in the study and authorization to release relevant protected health information to the study investigator Exclusion Criteria: - Fasting blood glucose > 7 mmol/L - Triglycerides = 2.3 mmol/L - Smoking tobacco products and marijuana - Thyroid problems - Previous history of cardiovascular disease, diabetes, liver or kidney disease, inflammatory bowel disease, celiac disease, short bowel syndrome, any malabsorptive syndrome, pancreatitis, gallbladder or biliary disease. - Presence of gastrointestinal disorder or surgeries within the past year. - Consuming prescription or non-prescription drug, herbal or nutritional supplements known to affect blood glucose or that could affect the outcome of the study as per investigator's judgement. - Known to be pregnant or lactating, or planning on becoming pregnant in the next 12 months. - Irregular menstrual cycles (i.e. frequent missed cycles), menopausal or post- menopausal - Unwillingness or inability to comply with the experimental procedures - Known intolerance, sensitivity or allergy to dairy products - Consumption of protein powders/protein supplements - Extreme dietary habits - Uncontrolled hypertension as defined by the average blood pressure measured at screening. - Weight gain or loss of at least 10 lbs in previous three months, and history of childhood overweight or obesity - Excessive alcohol intake - Restrained Eaters

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Dairy-based commercially available food products
Full-fat milk (3.25% milk, 250 mL), assortment of yogurts, and cheeses
Restrictive Eating
Dietitian will assist with 500 kcal/day reduction through limiting of macronutrients 45-65% energy from carbohydrates 20-35% energy from fat 10-35% energy from protein

Locations

Country Name City State
Canada Mount Saint Vincent University Halifax Nova Scotia
Canada Department of Nutritional Sciences Toronto Ontario

Sponsors (2)

Lead Sponsor Collaborator
University of Toronto Mount Saint Vincent University

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Other Fecal Collection Gut microbiome profiling Starting at the beginning of the study 0 week then at 12 weeks with a followed up at 16 weeks.
Other Change in blood glucose levels Each participant will attend 3 sessions in total Starting at the beginning of the study 0 week then at 12 weeks with a followed up at 16 weeks.
Other Change in fasting insulin (µIU/mL) levels in the blood Each participant will attend 3 sessions in total Change from baseline at 12 weeks
Other Change in gut hormone levels measured in the blood Each participant will attend 3 sessions in total Starting at the beginning of the study 0 week then at 12 weeks with a followed up at 16 weeks.
Other Change in triacylglycerol level (mg/dL) Each participant will attend 3 sessions in total Starting at the beginning of the study 0 week then at 12 weeks with a followed up at 16 weeks.
Other Change in HbA1c (mmol/mol) Each participant will attend 3 sessions in total Starting at the beginning of the study 0 week then at 12 weeks with a followed up at 16 weeks.
Other Change in red blood cells fatty acids Each participant will attend 3 sessions in total Starting at the beginning of the study 0 week then at 12 weeks with a followed up at 16 weeks.
Other Change in resting metabolic rate Each participant will attend 3 sessions in total measured by Indirect calorimetry Starting at the beginning of the study 0 week then at 12 weeks with a followed up at 16 weeks.
Other Change in short-chain fatty acids in the blood Each participant will attend 3 sessions in total Starting at the beginning of the study 0 week then at 12 weeks with a followed up at 16 weeks.
Other Change in waist and hip circumference in cm Each participant will attend 3 sessions in total Starting at the beginning of the study 0 week then at 12 weeks with a followed up at 16 weeks.
Other Change in lean body mass percentage measured by BodPod Each participant will attend 3 sessions in total Starting at the beginning of the study 0 week then at 12 weeks with a followed up at 16 weeks.
Primary Change in body weight Each participant will attend 8 sessions biweekly in total Starting at the beginning of the study 0 week then biweekly for 7 sessions up to 12 weeks with a followed up at 16 weeks.
See also
  Status Clinical Trial Phase
Completed NCT04085861 - Mental Health in Dancers; an Intervention Study N/A
Active, not recruiting NCT02558920 - Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
Not yet recruiting NCT06026631 - Lipidomic Characterization in Non-metastatic Breast Cancer Women Undergoing Surgery: a Pilot Study. N/A
Completed NCT03850990 - Effect of Gut-Cued Eating on BMI and Efficacy of Open-Label Placebo to Augment Weight Loss N/A
Not yet recruiting NCT03601273 - Bariatric Embolization Trial for the Obese Nonsurgical Phase 1
Completed NCT02899559 - Messages and Plans to Increase Gym Utilization N/A
Active, not recruiting NCT02557022 - Meta Analysis of the Effect of a Low Glycemic Index Diet and Glycemic Load on Body Weight N/A
Completed NCT02158130 - Effects of Aerobic Exercise Detraining N/A
Completed NCT02188251 - A Study Investigating the Effects of Activamp on Body Weight, Fat Loss, and Metabolic Markers in Healthy Overweight Participants Phase 2
Completed NCT02402985 - Comparison of a Plant Protein Diet to a Animal Protein Diet Emphasized in Type 2 Diabetics N/A
Completed NCT01665339 - Preload, Weight Management, Risk of Cardiovascular Disease Phase 3
Completed NCT01131871 - Innovative Approaches to Diet, Exercise and Activity Phase 2
Completed NCT01170390 - Oral Contraceptives and Body Mass Index Phase 4
Completed NCT02395835 - Methylation of the PPARg Promoter Region in Pregnancy N/A
Completed NCT00814554 - Effectiveness Evaluation of Three Strategies of Promotion of Healthy Dietary and Physical Activity Behaviours to Prevent Weight Excess Among Teenagers N/A
Completed NCT04901949 - The Course of Acute Pancreatitis in Patients With Different BMI Groups
Active, not recruiting NCT03843424 - Treatment Efforts Addressing Child Weight Management by Unifying Patients, Parents & Providers N/A
Active, not recruiting NCT03575897 - Serial Assessment of Body Fat Accrual in Very Preterm Infants N/A
Active, not recruiting NCT05601804 - TARGETing Healthy Weight Loss in the Context of Food Insecurity
Not yet recruiting NCT05004558 - Effects of Remote-based Resistance Training on Cardiometabolic Risk Factors, Cognitive Function, and Quality of Life in Adults Living With Alzheimer's Disease and/or Related Dementias N/A